The EU network of medicines agencies has given pharmaceutical stakeholders until 30 November to share their views on its planned strategy to 2028 so they can “help shape the direction of the network for the next few years.”
EU Drug Regulators Seek Help To Shape Network's Future Until 2028
More details on how the EU network of medicines agencies plan to leverage AI and foster competitiveness is now available in their draft 2025-2028 strategy, which they have published for comment.
